AbbVie, Iambic in Collaboration to Accelerate AI-driven Drug Discovery

 

• Multi-year partnership applies Iambic's AI platform to speed up small molecule drug discovery in immunology, neuroscience and oncology
• Companies to pursue programs with both first-in-class and best-in-class potential, combining Iambic's molecular superintelligence platform with AbbVie's therapeutic area expertise

https://news.abbvie.com/2026-09-21-AbbVie-and-Iambic-Announce-Collaboration-to-Accelerate-AI-driven-Drug-Discovery